EP1158984A4 - Inhibiteurs de prenyl-proteine transferase - Google Patents

Inhibiteurs de prenyl-proteine transferase

Info

Publication number
EP1158984A4
EP1158984A4 EP99971320A EP99971320A EP1158984A4 EP 1158984 A4 EP1158984 A4 EP 1158984A4 EP 99971320 A EP99971320 A EP 99971320A EP 99971320 A EP99971320 A EP 99971320A EP 1158984 A4 EP1158984 A4 EP 1158984A4
Authority
EP
European Patent Office
Prior art keywords
protein transferase
transferase inhibitors
prenyl protein
prenyl
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99971320A
Other languages
German (de)
English (en)
Other versions
EP1158984A1 (fr
Inventor
Jeffrey M Bergman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9900148.9A external-priority patent/GB9900148D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1158984A1 publication Critical patent/EP1158984A1/fr
Publication of EP1158984A4 publication Critical patent/EP1158984A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EP99971320A 1998-10-29 1999-10-26 Inhibiteurs de prenyl-proteine transferase Withdrawn EP1158984A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10617798P 1998-10-29 1998-10-29
US106177P 1998-10-29
GB9900148 1999-01-05
GBGB9900148.9A GB9900148D0 (en) 1999-01-05 1999-01-05 Inhibitors of prenyl-protein transferase
PCT/US1999/024948 WO2000025788A1 (fr) 1998-10-29 1999-10-26 Inhibiteurs de prenyl-proteine transferase

Publications (2)

Publication Number Publication Date
EP1158984A1 EP1158984A1 (fr) 2001-12-05
EP1158984A4 true EP1158984A4 (fr) 2003-05-21

Family

ID=26314955

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99971320A Withdrawn EP1158984A4 (fr) 1998-10-29 1999-10-26 Inhibiteurs de prenyl-proteine transferase

Country Status (5)

Country Link
EP (1) EP1158984A4 (fr)
JP (1) JP2002528504A (fr)
AU (1) AU762440B2 (fr)
CA (1) CA2348703A1 (fr)
WO (1) WO2000025788A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2740900C (fr) 2008-11-03 2019-09-24 Alethia Biotherapeutics Inc. Anticorps qui bloquent specifiquement l'activite biologique d'un antigene tumoral
SI3173427T1 (sl) 2011-03-31 2019-08-30 ADC Therapeutics SA, Protitelesa proti antigenu 1, povezanemu z ledvicami, in antigen vezavni fragmenti le-tega
US8921533B2 (en) 2011-07-25 2014-12-30 Chromatin Technologies Glycosylated valproic acid analogs and uses thereof
KR102102239B1 (ko) 2012-01-09 2020-04-21 에이디씨 테라퓨틱스 에스에이 유방암을 치료하기 위한 방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009985A1 (fr) * 1997-08-27 1999-03-04 Merck & Co., Inc. Inhibiteurs de prenyl-proteine-transferases
WO2000001701A1 (fr) * 1998-07-02 2000-01-13 Merck & Co., Inc. Inhibiteurs de prenyl-proteine transferase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225528A (en) * 1990-02-27 1993-07-06 Merck & Co., Inc. Cyclic hexapeptide oxytocin antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009985A1 (fr) * 1997-08-27 1999-03-04 Merck & Co., Inc. Inhibiteurs de prenyl-proteine-transferases
WO2000001701A1 (fr) * 1998-07-02 2000-01-13 Merck & Co., Inc. Inhibiteurs de prenyl-proteine transferase

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GELB M H ET AL: "PROTEIN PRENYLATION: FROM DISCOVERY TO PROSPECTS FOR CANCER TREATMENT", CURRENT OPINION IN CHEMICAL BIOLOGY, CURRENT BIOLOGY LTD, LONDON, GB, 1998, pages 40 - 48, XP002929841, ISSN: 1367-5931 *
See also references of WO0025788A1 *

Also Published As

Publication number Publication date
WO2000025788A1 (fr) 2000-05-11
JP2002528504A (ja) 2002-09-03
CA2348703A1 (fr) 2000-05-11
AU1228800A (en) 2000-05-22
EP1158984A1 (fr) 2001-12-05
AU762440B2 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
EP1324985A4 (fr) Inhibiteurs de la prenyl-proteine transferase
EP0891350A4 (fr) Inhibiteurs de farnesyle-proteine transferase
EP1165084A4 (fr) Inhibiteurs de prenyl-proteine transferases
EP1090012A4 (fr) Inhibiteurs de prenyl-proteine transferase
NO996571D0 (no) Inhibitorer for farnesyl-protein-transferase
EP1165082A4 (fr) Inhibiteurs de la prenyle-proteine transferase
EP1087770A4 (fr) Inhibiteurs de prenyl-proteine transferase
ATE546139T1 (de) Isoprentransferase proteine inhibitoren
EP0794789A4 (fr) Inhibiteurs des prenyle transferases
EP0841919A4 (fr) Inhibiteurs de la farnesyle-proteine transferase
EP0777475A4 (fr) Inhibiteurs de la farnesyle-proteine transferase
EE04309B1 (et) Farnesüül-proteiini transferaasi inhibiitorid
EE9800408A (et) Proteiinfarnesüültransferaasi inhibiitorid
EP0944388A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
EP1011669A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
ATE293622T1 (de) Farnesyl protein transferase inhibitoren
EP0904080A4 (fr) Inhibiteurs de farnesyle-proteine transferase
EP0891360A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
EP0783305A4 (fr) Inhibiteurs de farnesyle-proteine transferase
EP0812203A4 (fr) Inhibiteurs de geranylgeranyle-proteine transferase
EP1158982A4 (fr) Inhibiteurs de la prenyle-proteine transferase
EP1090011A4 (fr) Inhibiteurs de prenyl-proteine transferase
EP0891352A4 (fr) Inhibiteurs de la farnesyl-proteine transferase
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
EP1035852A4 (fr) Inhibiteurs de la farnesyl-proteine transferase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010529

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20010529;LT PAYMENT 20010529;LV PAYMENT 20010529;MK PAYMENT 20010529;RO PAYMENT 20010529;SI PAYMENT 20010529

A4 Supplementary search report drawn up and despatched

Effective date: 20030403

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31/496 B

Ipc: 7A 61K 31/277 B

Ipc: 7C 07C 255/50 B

Ipc: 7C 07D 295/073 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030621